30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Magellan Health Inc (MGLN)

Track

Stock chart
Ticker: MGLN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kamal Mostafa
CEO, Magellan Rx Management
1 sale — total 222,574 USD
Sale 9 Dec 2020
Value US$4,274,136.90 | Price 214.04 | Shares 97,208
Sale 16 Nov 2020
Value US$3,423,539.89 | Price 241.78 | Shares 95,249
Sale 13 Nov 2020
Value US$1,113,318.49 | Price 83.82 | Shares 13,282
Sale 10 Nov 2020
Value US$489,420.00 | Price 81.57 | Shares 6,000
Sale 5 Nov 2020
Value US$286,653.43 | Price 79.87 | Shares 3,589
Sale 4 Nov 2020
Value US$274,350.84 | Price 79.89 | Shares 3,434
Sale 4 Nov 2020
Value US$11,120.07 | Price 80.00 | Shares 139
Sale 4 Nov 2020
Value US$198,481.24 | Price 80.00 | Shares 2,481
Sale 16 Oct 2020
Value US$14,616.21 | Price 79.87 | Shares 183
Sale 7 Oct 2020
Value US$117,753.00 | Price 78.50 | Shares 1,500
Sale 6 Oct 2020
Value US$375,094.02 | Price 78.50 | Shares 4,778
Sale 5 Oct 2020
Value US$1,149,109.89 | Price 78.51 | Shares 14,637
Sale 8 Jun 2020
Value US$111,077.50 | Price 78.50 | Shares 1,415
Buy 15 May 2020
Value US$304,317.45 | Price 67.63 | Shares 4,500
Sale 2 Jan 2020
Value US$15,706.00 | Price 78.53 | Shares 200
Sale 30 Dec 2019
Value US$8,164.00 | Price 78.50 | Shares 104
Sale 27 Dec 2019
Value US$47,596.94 | Price 78.54 | Shares 606
Sale 26 Dec 2019
Value US$150,986.84 | Price 78.52 | Shares 1,923
Sale 24 Dec 2019
Value US$480,166.05 | Price 78.54 | Shares 6,114
Sale 16 Dec 2019
Value US$450,886.27 | Price 78.62 | Shares 5,735
Sale 9 Dec 2019
Value US$1,319,742.40 | Price 78.72 | Shares 16,766
Sale 2 Jul 2018
Value US$1,282,060.62 | Price 95.86 | Shares 13,375
Sale 1 Jun 2018
Value US$1,233,326.14 | Price 92.21 | Shares 13,375
Sale 1 May 2018
Value US$1,150,576.35 | Price 86.02 | Shares 13,375
Sale 2 Apr 2018
Value US$176,929.20 | Price 106.20 | Shares 1,666
Sale 2 Apr 2018
Value US$1,384,582.68 | Price 103.52 | Shares 13,375
Sale 5 Mar 2018
Value US$1,527,967.52 | Price 99.04 | Shares 15,428
Sale 5 Mar 2018
Value US$2,265,697.84 | Price 99.05 | Shares 22,875
Sale 1 Mar 2018
Value US$1,353,496.50 | Price 101.20 | Shares 13,375
Sale 1 Feb 2018
Value US$1,326,765.22 | Price 99.20 | Shares 13,375
Sale 3 Jan 2018
Value US$2,893,027.64 | Price 96.16 | Shares 30,086
Sale 2 Jan 2018
Value US$1,282,428.64 | Price 95.94 | Shares 13,367
Sale 2 Jan 2018
Value US$1,675,782.15 | Price 96.07 | Shares 17,443
Sale 4 Dec 2017
Value US$200,560.00 | Price 92.00 | Shares 2,180
Sale 4 Dec 2017
Value US$5,574,585.69 | Price 93.99 | Shares 59,313
Sale 1 Dec 2017
Value US$737,137.00 | Price 89.08 | Shares 8,275
Planned sale 1 Nov 2017
Value US$835,751.34 | Price 89.20 | Shares 9,369
Planned sale 1 Nov 2017
Value US$106,168.00 | Price 92.00 | Shares 1,154
Sale 4 Oct 2017
Value US$218,047.50 | Price 88.10 | Shares 2,475
Sale 4 Oct 2017
Value US$440,000.00 | Price 88.00 | Shares 5,000
Sale 3 Oct 2017
Value US$440,000.00 | Price 88.00 | Shares 5,000
Sale 3 Oct 2017
Value US$2,621,241.59 | Price 87.31 | Shares 30,021
Sale 2 Oct 2017
Value US$1,638,688.50 | Price 86.22 | Shares 19,007
Sale 29 Sep 2017
Value US$1,595,316.85 | Price 86.18 | Shares 18,511
Sale 28 Sep 2017
Value US$415,781.93 | Price 85.76 | Shares 4,848
Sale 28 Sep 2017
Value US$2,173,452.02 | Price 85.85 | Shares 25,316
Sale 27 Sep 2017
Value US$122,124.96 | Price 86.06 | Shares 1,419
Sale 27 Sep 2017
Value US$1,577,130.83 | Price 85.24 | Shares 18,502
Sale 27 Sep 2017
Value US$3,036,927.68 | Price 85.17 | Shares 35,658
Sale 27 Sep 2017
Value US$51,634.98 | Price 86.06 | Shares 600
Sale 27 Sep 2017
Value US$1,580,373.40 | Price 85.31 | Shares 18,526
Sale 15 Sep 2017
Value US$199,366.00 | Price 83.00 | Shares 2,402
Sale 15 Sep 2017
Value US$248,724.00 | Price 84.00 | Shares 2,961
Sale 14 Sep 2017
Value US$1,500,162.86 | Price 83.05 | Shares 18,063
Sale 13 Sep 2017
Value US$48,555.00 | Price 83.00 | Shares 585
Sale 13 Sep 2017
Value US$1,170,882.83 | Price 83.06 | Shares 14,096
Sale 12 Sep 2017
Value US$1,577.00 | Price 83.00 | Shares 19
Sale 11 Sep 2017
Value US$55,610.00 | Price 83.00 | Shares 670
Sale 11 Sep 2017
Value US$199,200.00 | Price 83.00 | Shares 2,400
Sale 8 Sep 2017
Value US$510,918.43 | Price 81.53 | Shares 6,267
Sale 7 Sep 2017
Value US$83,870.30 | Price 81.19 | Shares 1,033
Sale 5 Sep 2017
Value US$93,669.45 | Price 80.96 | Shares 1,157
Sale 25 Jul 2017
Value US$367,819.66 | Price 80.68 | Shares 4,559
Sale 24 Jul 2017
Value US$2,595,581.97 | Price 80.12 | Shares 32,398
Sale 21 Jul 2017
Value US$94,102.23 | Price 80.02 | Shares 1,176
Sale 20 Jul 2017
Value US$1,286,751.34 | Price 80.06 | Shares 16,073
Sale 20 Jul 2017
Value US$88,727.54 | Price 80.01 | Shares 1,109
Sale 17 Jul 2017
Value US$48,060.00 | Price 80.10 | Shares 600
Sale 14 Jul 2017
Value US$2,234,939.99 | Price 80.07 | Shares 27,914
Sale 14 Jul 2017
Value US$1,130,685.24 | Price 80.11 | Shares 14,114
Sale 24 Feb 2017
Value US$8,210.00 | Price 82.10 | Shares 100
Sale 24 Feb 2017
Value US$8,105.00 | Price 81.05 | Shares 100
Sale 24 Feb 2017
Value US$8,000.00 | Price 80.00 | Shares 100
Sale 23 Feb 2017
Value US$24,335.01 | Price 81.12 | Shares 300
Sale 23 Feb 2017
Value US$1,036,515.96 | Price 80.28 | Shares 12,912
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-11 2020-12-09 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
97,208 +33.3%
214.04
US$4,274,137 		97,208 +33.3% 214.04 US$4,274,137
2020-11-17 2020-11-16 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
95,249 +14.7%
241.78
US$3,423,540 		95,249 +14.7% 241.78 US$3,423,540
2020-11-17 2020-11-13 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
75,667 +25.1%
415.68
US$3,152,651 		75,667 +25.1% 415.68 US$3,152,651
2020-11-12 2020-11-10 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
6,000 -51.6%
81.57
US$489,420 		6,000 -51.6% 81.57 US$489,420
2020-11-06 2020-11-05 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
3,589 -39.0%
79.87
US$286,653 		3,589 -39.0% 79.87 US$286,653
2020-11-06 2020-11-04 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
3,434 -37.9%
79.89
US$274,351 		3,434 -37.9% 79.89 US$274,351
2020-11-06 2020-11-04 S Sale
WEST JEFFREY N

SVP & Controller

Officer
139 -0.6%
80.00
US$11,120 		139 -0.6% 80.00 US$11,120
2020-11-06 2020-11-04 S Sale
WEST JEFFREY N

SVP & Controller

Officer
2,481 -9.7%
80.00
US$198,481 		2,481 -9.7% 80.00 US$198,481
2020-10-20 2020-10-16 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
183 -3.2%
79.87
US$14,616 		183 -3.2% 79.87 US$14,616
2020-10-07 2020-10-07 S Sale
WEST JEFFREY N

SVP & Controller

Officer
1,500 -6.1%
78.50
US$117,753 		1,500 -6.1% 78.50 US$117,753
2020-10-07 2020-10-06 S Sale
WEST JEFFREY N

SVP & Controller

Officer
4,778 -17.2%
78.50
US$375,094 		4,778 -17.2% 78.50 US$375,094
2020-10-07 2020-10-05 S Sale
WEST JEFFREY N

SVP & Controller

Officer
14,637 -38.9%
78.51
US$1,149,110 		14,637 -38.9% 78.51 US$1,149,110
2020-06-10 2020-06-08 S Sale
WEST JEFFREY N

SVP & Controller

Officer
1,415 -5.8%
78.50
US$111,078 		1,415 -5.8% 78.50 US$111,078
2020-05-19 2020-05-15 B Purchase
0.8
MURRAY JAMES E

President and COO

Officer
4,500 +inf%
67.63
US$304,317 		4,500 +inf% 67.63 US$304,317
2020-01-03 2020-01-02 S Sale
WEST JEFFREY N

SVP & Controller
200 -1.0%
78.53
US$15,706 		200 -1.0% 78.53 US$15,706
2019-12-31 2019-12-30 S Sale WEST JEFFREY N

SVP & Controller

Officer
104 -0.5%
78.50
US$8,164 		104 -0.5% 78.50 US$8,164
2019-12-30 2019-12-27 S Sale WEST JEFFREY N

SVP & Controller

Officer
606 -2.9%
78.54
US$47,597 		606 -2.9% 78.54 US$47,597
2019-12-27 2019-12-26 S Sale WEST JEFFREY N

SVP & Controller

Officer
1,923 -8.7%
78.52
US$150,987 		1,923 -8.7% 78.52 US$150,987
2019-12-26 2019-12-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
6,114 -23.3%
78.54
US$480,166 		6,114 -23.3% 78.54 US$480,166
2019-12-17 2019-12-16 S Sale WEST JEFFREY N

SVP & Controller

Officer
5,735 -22.1%
78.62
US$450,886 		5,735 -22.1% 78.62 US$450,886
2019-12-11 2019-12-09 S Sale Kamal Mostafa

CEO, Magellan Rx Management

Officer
16,766 -85.7%
78.72
US$1,319,742 		16,766 -85.7% 78.72 US$1,319,742
2018-07-03 2018-07-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -30.5%
95.86
US$1,282,061 		13,375 -30.5% 95.86 US$1,282,061
2018-06-04 2018-06-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -30.5%
92.21
US$1,233,326 		13,375 -30.5% 92.21 US$1,233,326
2018-05-02 2018-05-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -23.2%
86.02
US$1,150,576 		13,375 -23.2% 86.02 US$1,150,576
2018-04-04 2018-04-02 S Sale Kamal Mostafa

CEO, Magellan Rx Management

Officer
1,666 -100.0%
106.20
US$176,929 		1,666 -100.0% 106.20 US$176,929
2018-04-04 2018-04-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -23.2%
103.52
US$1,384,583 		13,375 -23.2% 103.52 US$1,384,583
2018-03-06 2018-03-05 S Sale Kamal Mostafa

CEO, Magellan Rx Management
15,428 -100.0%
99.04
US$1,527,968 		15,428 -100.0% 99.04 US$1,527,968
2018-03-06 2018-03-05 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
22,875 -63.0%
99.05
US$2,265,698 		22,875 -63.0% 99.05 US$2,265,698
2018-03-02 2018-03-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -31.2%
101.20
US$1,353,496 		13,375 -31.2% 101.20 US$1,353,496
2018-02-02 2018-02-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -31.2%
99.20
US$1,326,765 		13,375 -31.2% 99.20 US$1,326,765
2018-01-04 2018-01-03 S Sale Rubin Jonathan N

Chief Financial Officer

Officer
30,086 -53.2%
96.16
US$2,893,028 		30,086 -53.2% 96.16 US$2,893,028
2018-01-03 2018-01-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,367 -31.2%
95.94
US$1,282,429 		13,367 -31.2% 95.94 US$1,282,429
2018-01-03 2018-01-02 S Sale Rubin Jonathan N

Chief Financial Officer

Officer
17,443 -39.7%
96.07
US$1,675,782 		17,443 -39.7% 96.07 US$1,675,782
2017-12-06 2017-12-04 S Sale Kamal Mostafa

CEO, Magellan Rx Management
2,180 -100.0%
92.00
US$200,560 		2,180 -100.0% 92.00 US$200,560
2017-12-05 2017-12-04 S Sale Lewis Clapper Caskie

Chief Human Resources Officer
59,313 -76.3%
93.99
US$5,574,586 		59,313 -76.3% 93.99 US$5,574,586
2017-12-04 2017-12-01 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
8,275 -38.1%
89.08
US$737,137 		8,275 -38.1% 89.08 US$737,137
2017-11-02 2017-11-01 PlS Planned sale GREGOIRE DANIEL N

General Counsel and Secretary
9,369 -41.0%
89.20
US$835,751 		9,369 -41.0% 89.20 US$835,751
2017-11-02 2017-11-01 PlS Planned sale Kamal Mostafa

CEO, Magellan Rx Management
1,154 -100.0%
92.00
US$106,168 		1,154 -100.0% 92.00 US$106,168
2017-10-05 2017-10-04 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
2,475 -15.5%
88.10
US$218,048 		2,475 -15.5% 88.10 US$218,048
2017-10-05 2017-10-04 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
5,000 -23.9%
88.00
US$440,000 		5,000 -23.9% 88.00 US$440,000
2017-10-05 2017-10-03 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
5,000 -27.1%
88.00
US$440,000 		5,000 -27.1% 88.00 US$440,000
2017-10-04 2017-10-03 S Sale WEST JEFFREY N

SVP & Controller
30,021 -68.3%
87.31
US$2,621,242 		30,021 -68.3% 87.31 US$2,621,242
2017-10-03 2017-10-02 S Sale WEST JEFFREY N

SVP & Controller
19,007 -57.7%
86.22
US$1,638,689 		19,007 -57.7% 86.22 US$1,638,689
2017-10-03 2017-09-29 S Sale WEST JEFFREY N

SVP & Controller
18,511 -57.1%
86.18
US$1,595,317 		18,511 -57.1% 86.18 US$1,595,317
2017-09-29 2017-09-28 S Sale Kamal Mostafa

CEO, Magellan Rx Management
4,848 -100.0%
85.76
US$415,782 		4,848 -100.0% 85.76 US$415,782
2017-09-29 2017-09-28 S Sale WEST JEFFREY N

SVP & Controller
25,316 -64.5%
85.85
US$2,173,452 		25,316 -64.5% 85.85 US$2,173,452
2017-09-29 2017-09-27 S Sale WEST JEFFREY N

SVP & Controller
1,419 -9.2%
86.06
US$122,125 		1,419 -9.2% 86.06 US$122,125
2017-09-29 2017-09-27 S Sale WEST JEFFREY N

SVP & Controller
18,502 -54.7%
85.24
US$1,577,131 		18,502 -54.7% 85.24 US$1,577,131
2017-09-28 2017-09-27 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
35,658 -72.6%
85.17
US$3,036,928 		35,658 -72.6% 85.17 US$3,036,928
2017-09-28 2017-09-27 S Sale Kamal Mostafa

CEO, Magellan Rx Management
600 -100.0%
86.06
US$51,635 		600 -100.0% 86.06 US$51,635
2017-09-28 2017-09-27 S Sale Kamal Mostafa

CEO, Magellan Rx Management
18,526 -96.9%
85.31
US$1,580,373 		18,526 -96.9% 85.31 US$1,580,373
2017-09-18 2017-09-15 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
2,402 -15.1%
83.00
US$199,366 		2,402 -15.1% 83.00 US$199,366
2017-09-18 2017-09-15 S Sale Kamal Mostafa

CEO, Magellan Rx Management
2,961 -100.0%
84.00
US$248,724 		2,961 -100.0% 84.00 US$248,724
2017-09-18 2017-09-14 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
18,063 -57.3%
83.05
US$1,500,163 		18,063 -57.3% 83.05 US$1,500,163
2017-09-14 2017-09-13 S Sale Kamal Mostafa

CEO, Magellan Rx Management
585 -100.0%
83.00
US$48,555 		585 -100.0% 83.00 US$48,555
2017-09-14 2017-09-13 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
14,096 -51.2%
83.06
US$1,170,883 		14,096 -51.2% 83.06 US$1,170,883
2017-09-14 2017-09-12 S Sale Kamal Mostafa

CEO, Magellan Rx Management
19 -100.0%
83.00
US$1,577 		19 -100.0% 83.00 US$1,577
2017-09-12 2017-09-11 S Sale Kamal Mostafa

CEO, Magellan Rx Management
670 -100.0%
83.00
US$55,610 		670 -100.0% 83.00 US$55,610
2017-09-12 2017-09-11 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
2,400 -15.1%
83.00
US$199,200 		2,400 -15.1% 83.00 US$199,200
2017-09-11 2017-09-08 S Sale Kamal Mostafa

CEO, Magellan Rx Management
6,267 -100.0%
81.53
US$510,918 		6,267 -100.0% 81.53 US$510,918
2017-09-08 2017-09-07 S Sale Kamal Mostafa

CEO, Magellan Rx Management
1,033 -100.0%
81.19
US$83,870 		1,033 -100.0% 81.19 US$83,870
2017-09-08 2017-09-05 S Sale Kamal Mostafa

CEO, Magellan Rx Management
1,157 -100.0%
80.96
US$93,669 		1,157 -100.0% 80.96 US$93,669
2017-07-26 2017-07-25 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
4,559 -25.3%
80.68
US$367,820 		4,559 -25.3% 80.68 US$367,820
2017-07-25 2017-07-24 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
32,398 -70.7%
80.12
US$2,595,582 		32,398 -70.7% 80.12 US$2,595,582
2017-07-25 2017-07-21 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
1,176 -8.0%
80.02
US$94,102 		1,176 -8.0% 80.02 US$94,102
2017-07-21 2017-07-20 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
16,073 -54.4%
80.06
US$1,286,751 		16,073 -54.4% 80.06 US$1,286,751
2017-07-21 2017-07-20 S Sale WEST JEFFREY N

SVP & Controller

Officer
1,109 -7.4%
80.01
US$88,728 		1,109 -7.4% 80.01 US$88,728
2017-07-18 2017-07-17 S Sale WEST JEFFREY N

SVP & Controller

Officer
600 -4.1%
80.10
US$48,060 		600 -4.1% 80.10 US$48,060
2017-07-18 2017-07-14 S Sale WEST JEFFREY N

SVP & Controller

Officer
27,914 -66.7%
80.07
US$2,234,940 		27,914 -66.7% 80.07 US$2,234,940
2017-07-17 2017-07-14 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
14,114 -51.2%
80.11
US$1,130,685 		14,114 -51.2% 80.11 US$1,130,685
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
82.10
US$8,210 		100 -0.9% 82.10 US$8,210
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
81.05
US$8,105 		100 -0.9% 81.05 US$8,105
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
80.00
US$8,000 		100 -0.9% 80.00 US$8,000
2017-02-27 2017-02-23 S Sale WEST JEFFREY N

SVP & Controller

Officer
300 -2.5%
81.12
US$24,335 		300 -2.5% 81.12 US$24,335
2017-02-27 2017-02-23 S Sale WEST JEFFREY N

SVP & Controller

Officer
12,912 -51.9%
80.28
US$1,036,516 		12,912 -51.9% 80.28 US$1,036,516
Explore more

More insider trading research around Magellan Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America